Bio Green Med Solution Inc Preferred Stock
BGMSP
BGMSP was delisted on the 20th of March, 2026.
2 hedge funds and large institutions have $82K invested in Bio Green Med Solution Inc Preferred Stock in 2017 Q2 according to their latest regulatory filings, with funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 1 closing their positions.
0.29% less ownership
Funds ownership: 4.2% → 3.91% (-0.29%)
9% less capital invested
Capital invested by funds: $90K → $82K (-$8K)
33% less funds holding
Funds holding: 3 → 2 (-1)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 1
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
-$4K |
| 2 |
TRCT
Tower Research Capital (TRC)
New York
|
-$2.5K |
BGMSP Hedge Fund Activity: Q2 2017 in Review
2 of the 4,012 institutional investors tracked by Wall St. Rank reported a position in Bio Green Med Solution Inc Preferred Stock (BGMSP) for Q2 2017, worth a combined $82K — down 8.9% from $90K a quarter earlier.
Sellers outnumbered buyers: 1 fund closed out of BGMSP and 0 opened new positions — a net loss of 1 holder — while 1 trimmed existing stakes and 0 added.
The largest seller was UBS Group, exiting entirely with an estimated $4K sold.
- 2 institutional investors held Bio Green Med Solution Inc Preferred Stock (BGMSP) as of Q2 2017, down from 3 in Q1 2017.
- Funds reported $82K of Bio Green Med Solution Inc Preferred Stock stock for Q2 2017, down 8.9% quarter-over-quarter.
- 0 funds opened new Bio Green Med Solution Inc Preferred Stock positions in Q2 2017 and 1 closed out, a net change of -1 holder.
- The largest Bio Green Med Solution Inc Preferred Stock seller in Q2 2017 was UBS Group, an estimated $4K sold.
Based on aggregated 13F filings for Q2 2017.